CoChat

Thioredoxin Reductase 2 (TXNRD2) Mutation Associated With Familial Glucocorticoid Deficiency (FGD)

Open access
Prasad, Rathi, Chan, Li F., Hughes, Claire R., Kaski, Juan P., Kowalczyk, Julia C., Savage, Martin O., Peters, Catherine J., Nathwani, Nisha, Clark, Adrian J. L., Storr, Helen L., Metherell, Louise A. · 2014 · The Journal of Clinical Endocrinology & Metabolism
Cited by 138

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Context: Classic ACTH resistance, due to disruption of ACTH signaling, accounts for the majority of cases of familial glucocorticoid deficiency (FGD). Recently FGD cases caused by mutations in the mitochondrial antioxidant, nicotinamide nucleotide transhydrogenase, have highlighted the importance of redox regulation in steroidogenesis. Objective: We hypothesized that other components of mitochondrial antioxidant systems would be good candidates in the etiology of FGD. Design: Whole-exome sequencing was performed on three related patients, and segregation of putative causal variants confirmed by Sanger sequencing of all family members. A TXNRD2-knockdown H295R cell line was created to investigate redox homeostasis. Setting: The study was conducted on patients from three pediatric centers in the United Kingdom. Patients: Seven individuals from a consanguineous Kashmiri kindred, six of whom presented with FGD between 0.1 and 10.8 years, participated in the study. Interventions: There were no interventions. Main Outcome Measure: Identification and functional interrogation of a novel homozygous mutation segregating with the disease trait were measured. Results: A stop gain mutation, p.Y447X in TXNRD2, encoding the mitochondrial selenoprotein thioredoxin reductase 2 (TXNRD2) was identified and segregated with disease in this extended kindred. RT-PCR and Western blotting revealed complete absence of TXNRD2 in patients homozygous for the mutation. TXNRD2 deficiency leads to impaired redox homeostasis in a human adrenocortical cell line. Conclusion: In contrast to the Txnrd2-knockout mouse model, in which embryonic lethality as a consequence of hematopoietic and cardiac defects is described, absence of TXNRD2 in humans leads to glucocorticoid deficiency. This is the first report of a homozygous mutation in any component of the thioredoxin antioxidant system leading to inherited disease in humans.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2013-3844

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 17

  1. Meimaridou, 2013, Familial glucocorticoid deficiency: new genes and mechanisms, Mol Cell Endocrinol, 371, 195, 10.1016/j.mce.2012.12.010 · DOI
  2. Clark, 1993, Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor, Lancet, 341, 461, 10.1016/0140-6736(93)90208-X · DOI · Paper page
  3. Hughes, 2012, MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans, J Clin Invest, 122, 814, 10.1172/JCI60224 · DOI · Paper page
  4. Meimaridou, 2012, Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency, Nat Genet, 44, 740, 10.1038/ng.2299 · DOI · Paper page
  5. Darrah, 2007, Multifunctional TH1 cells define a correlate of vaccine mediated protection against Leishmania major, Nat Med, 13, 843, 10.1038/nm1592 · DOI · Paper page
  6. Biterova, 2005, Crystal structures of oxidised and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism, Proc Natl Acad Sci USA, 102, 15018, 10.1073/pnas.0504218102 · DOI · Paper page
  7. Kil, 2012, Feedback control of adrenal steroidogenesis via H2O2-dependent, reversible inactivation of peroxiredoxin III in mitochondria, Mol Cell, 46, 584, 10.1016/j.molcel.2012.05.030 · DOI · Paper page
  8. Godoy, 2011, Redox atlas of the mouse. Immunohistochemical detection of glutaredoxin-, peroxiredoxin-, and thioredoxin-family proteins in various tissues of the laboratory mouse, Biochim Biophys Acta, 1810, 2, 10.1016/j.bbagen.2010.05.006 · DOI
  9. Kryukov, 2003, Characterization of mammalian selenoproteomes, Science, 300, 1439, 10.1126/science.1083516 · DOI · Paper page
  10. Hanschmann, 2010, Both thioredoxin 2 and glutaredoxin 2 contribute to the reduction of the mitochondrial 2-Cys peroxiredoxin Prx3, J Biol Chem, 285, 40699, 10.1074/jbc.M110.185827 · DOI · Paper page
  11. Zhang, 2007, Mitochondrial thioredoxin-2/peroxiredoxin-3 system functions in parallel with mitochondrial GSH system in protection against oxidative stress, Arch Biochem Biophys, 465, 119, 10.1016/j.abb.2007.05.001 · DOI
  12. Diemer, 2003, Reactive oxygen disrupts mitochondria in MA-10 tumor Leydig cells and inhibits steroidogenic acute regulatory (StAR) protein and steroidogenesis, Endocrinology, 144, 2882, 10.1210/en.2002-0090 · DOI · Paper page
  13. Hirano, 2006, ALADIN1482S causes selective failure of nuclear protein import and hypersensitivity to oxidative stress on triple A syndrome, Proc Natl Acad Sci USA, 103, 2298, 10.1073/pnas.0505598103 · DOI · Paper page
  14. Sibbing, 2011, Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy, Eur Heart J, 32, 1121, 10.1093/eurheartj/ehq507 · DOI
  15. Yagi, 2003, Role of TBX1 in human del22q11.2 syndrome, Lancet, 362, 1366, 10.1016/S0140-6736(03)14632-6 · DOI · Paper page
  16. Moon, 2006, Crkl deficiency disrupts Fgf8 signaling in a mouse model of 22q11 deletion syndromes, Dev Cell, 10, 71, 10.1016/j.devcel.2005.12.003 · DOI
  17. Rajamohan, 2012, NADPH oxidase-derived H2O2 contributes to angiotensin II-induced aldosterone synthesis in human and rat adrenal cortical cells, Antoxid Redox, 17, 445, 10.1089/ars.2011.4176 · DOI

Cited by

See all 138

Metadata

Authors
Prasad, R., Chan, L. F., Hughes, C. R., Kaski, J. P., Kowalczyk, J. C., Savage, M. O., Peters, C. J., Nathwani, N., Clark, A. J. L., Storr, H. L., & Metherell, L. A.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2014-08-01
Volume
99
Issue
8
Pages
E1556-E1563
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W1983428384
Cited by
138
References
7
FWCI
9.10
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Thioredoxin Reductase 2 (TXNRD2) Mutation Associated With Familial Glucocorticoid Deficiency (FGD). https://app.cochat.ai/papers/10.1210/jc.2013-3844
The paper
Prasad, R., Chan, L. F., Hughes, C. R., Kaski, J. P., Kowalczyk, J. C., Savage, M. O., Peters, C. J., Nathwani, N., Clark, A. J. L., Storr, H. L., & Metherell, L. A. (2014). Thioredoxin Reductase 2 (TXNRD2) Mutation Associated With Familial Glucocorticoid Deficiency (FGD). The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2013-3844

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.